The effectiveness of β-blockers after myocardial infarction in patients with type 2 diabetes

Diabetes Care

Volumn 28, Issue 9, 2005, Pages 2113-2117

  McDonald, Charlotte G ^a,d   Majumdar, Sumit R ^b,c   Mahon, Jeffrey L ^a   Johnson, Jeffrey A ^b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c INSTITUTE OF HEALTH ECONOMICS   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; CAUSE OF DEATH; COHORT STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 24144500332     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.9.2113     Document Type: Article

References (26)

1. Gu K, Cowie CC, Harris MI: Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 21:1138-1145, 1998
2. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393, 2003
3. Yusuf S, Peto R, Lewis J, Collins R, Sleight P: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27:335-371, 1985
4. Freemantle N, Cleland J, Young P, Mason J, Harrison J: Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318:1730-1737, 1999
5. Majumdar SR: Beta-blockers for the treatment of hypertension in patients with diabetes: exploring the contraindication myth. Cardiovasc Drugs Ther 13:435-439, 1999
6. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE III, Weaver WD: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 94:2341-2350, 1996
7. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247:1707-1714, 1982
8. Hjalmarson A, Herlitz J, Holmberg S, Ryden L, Swedberg K, Vedin A, Waagstein F, Waldenstrom A, Waldenstrom J, Wedel H, Wilhelmsen L, Wilhelmsson C: The Goteborg Metoprolol Trial: effects on mortality and morbidity in acute myocardial infarction. Circulation 67:126-132, 1983
9. Gundersen T, Kjekshus J: Timolol treatment after myocardial infarction in diabetic patients. Diabetes Care 6:285-290, 1983
10. The MIAMI Trial Research Group: Metoprolol in acute myocardial infarction (MI-AMI): a randomised placebo-controlled international trial. Eur Heart J 6:199-226, 1985
11. Malmberg K, Herlitz J, Hjalmarson A, Ryden L: Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction: retrospective data from two large studies. Eur Heart J 10:423-428, 1989
12. Kjekshus J, Gilpin E, Cali G, Blackey AR, Henning H, Ross J Jr: Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J 11:43-50, 1990
13. Jonas M, Reicher-Reiss H, Boyko V, Shotan A, Mandelzweig L, Goldbourt U, Behar S: Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: Bezafibrate Infarction Prevention (BIP) Study Group. Am J Cardiol 77: 1273-1277, 1996
14. Gottlieb SS, McCarter RJ, Vogel RA: Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339:489-497, 1998
15. Chen J, Marciniak TA, Radford MJ, Wang Y, Krumholz HM: Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients: results from the National Cooperative Cardiovascular Project. J Am Coll Cardiol 34: 1388-1394, 1999
16. Downey W, Beck P, McNutt M: Health Databases in Saskatchewan. In Pharmacoepidemiology. 3rd ed. Strom BL, Ed. New York, Wiley, 2000, p. 325-346
17. Johnson JA, Majumdar SR, Simpson SH, Toth EL: Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care 25:2244-2248, 2002
18. Rawson NS, Malcolm E: Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med 14:2627-2643, 1995
19. Von Korff M, Wagner EH, Saunders K: A chronic disease score from automated pharmacy data. J Clin Epidemiol 45:197-203, 1992
20. Tsuyuki RT, Olson KL, Teo KK: Nitroglycerin as an indicator for the presence of coronary heart disease. Can Pharm J 132: 32-36, 1999
21. Turner CJ, Parfrey P, Ryan K, Miller R, Brown A: Community pharmacist outreach program directed at physicians treating congestive heart failure. Am J Health Syst Pharm 57:747-752, 2000
22. Udris EM, Au DH, McDonell MB, Chen L, Martin DC, Tierney WM, Fihn SD: Comparing methods to identify general internal medicine clinic patients with chronic heart failure. Am Heart J 142:1003-1009, 2001
23. Eurich DT, Majumdar SR, Tsuyuki RT, Johnson JA: Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetes. Diabetes Care 27: 1330-1334, 2004
24. Yee A, Majumdar SR, Simpson SH, McAlister FA, Tsuyuki RT, Johnson JA: Statin use in type 2 diabetes mellitus is associated with a delay in starting insulin. Diabet Med 21:962-967, 2004
25. Ko DT, Mamdani M, Alter DA: Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 291:1864-1870, 2004
26. Lappe JM, Muhlestein JB, Lappe DL, Badger RS, Bair TL, Brockman R, French TK, Hofmann LC, Home BD, Kralick-Goldberg S, Nicponski N, Orton JA, Pearson RR, Renlund DG, Rimmasch H, Roberts C, Anderson JL: Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program. Ann Intern Med 141: 446-453, 2004